Daiichi Sankyo Makes Offer To Own Majority Of India's Zenotech
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo has offered to buy an additional 20 percent of Zenotech Laboratories of India, giving the Japanese firm a majority interest through its own ownership of Ranbaxy Laboratories